ESR1 and breast cancer: Meanwhile, microRNAs (miRNAs) have been abundantly explored in human cancers, such as anti-miR-203 restricts estrogen receptor (ER)-positive breast cancer growth and stemness via modulating SOCS3[14], and the emerging role of miRNAs has also been reported in AML [15].